Jasper Therapeutics, Inc., (JSPR) Social Stream
JASPER THERAPEUTICS INC (JSPR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering JSPR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-20 | 3 | $21 | $19 | $20 | $6.63 | 201.66% |
| 2022-02-27 | 4 | $21 | $19 | $20 | $6.63 | 201.66% |
| 2022-08-16 | 4 | $21 | $10 | $16.666 | $6.63 | 151.37% |
| 2022-11-01 | 4 | $21 | $4 | $11.666 | $6.63 | 75.96% |
| 2023-02-08 | 4 | $10 | $4 | $7.333 | $6.63 | 10.6% |
| 2023-02-13 | 4 | $8 | $4 | $6 | $6.63 | -9.5% |
| 2023-03-09 | 3 | $8 | $6.85 | $7.425 | $6.63 | 11.99% |
| 2023-05-16 | 4 | $8 | $6 | $6.95 | $6.63 | 4.83% |
| 2023-10-09 | 5 | $8 | $6 | $6.962 | $6.63 | 5.01% |
The Trend in the Analyst Price Target
JSPR's average price target has moved up $0.17 over the prior 39 weeks.
Over the past 39 weeks, JSPR's average upside potential has been 456.36%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-16 | 4 | 8 | 6.00 | 6.950 | 1.83 | 279.78% |
| 2023-05-16 | 4 | 8 | 6.00 | 6.950 | 1.55 | 348.39% |
| 2023-08-15 | 5 | 8 | 6.00 | 6.962 | 1.44 | 383.47% |
| 2023-10-09 | 4 | 8 | 6.85 | 7.283 | 0.93 | 683.12% |
| 2023-10-09 | 3 | 8 | 6.85 | 7.283 | 0.93 | 683.12% |
JSPR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 24 months, JSPR's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- JASPER THERAPEUTICS INC's average analyst price target is higher than 184.1% of all US stocks.
- In terms of how JASPER THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 190.36% of that group.
- JASPER THERAPEUTICS INC's variance in analysts' estimates is lower than -508.39% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, JASPER THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 543.63% of them.
In the Pharmaceutical Products industry, CABA, AVRO, and MGTX are the three stocks most similar to JASPER THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is JSPR a Buy, Hold or Sell? See the POWR Ratings now!